Home » Topics » Regulatory » Patents

Patents
RSS

Nebivolol claimed for oxidative stress-related disorders

Sep. 13, 1996

Inhibitors of ceramide-mediated signal transduction

Sep. 13, 1996

Novel PAF and 5-LO inhibitors reported by Sunkyong

Sep. 13, 1996

Improved agents for asthma

Sep. 13, 1996

Antioxidants isolated by Japanese researchers

Sep. 13, 1996

Neuronal calcium channel antagonists for stroke

Sep. 13, 1996

Lilly reports new treatment for attention deficit/hyperactivity disorder

Sep. 13, 1996

Hoechst Marion Roussel claims compound for neurodegenerative disorders

Sep. 13, 1996

Rhodanines for multiple sclerosis

Sep. 13, 1996

New formulation of selegiline

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...